← Back to Search

Vibrogent Smartphone Application for Mucositis

N/A

Waitlist Available

Led By Harry Quon, M.D.

Research Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a smartphone app called VibrentTM to help people with head and neck cancer manage pain from radiation sores. The app provides information and reminders about pain and medication, and securely shares this data with doctors. It aims to improve pain management for patients undergoing radiation therapy.

Eligible Conditions

Mucositis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from baseline in "out of clinic" pain at 2 months

Secondary study objectives

Change from baseline mucositis pain at 2 months

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Vibrent Smartphone ApplicationExperimental Treatment1 Intervention

We propose to pilot the application of the mobile application "VibrentTM" (research procedure) during a course of head and neck radiotherapy for eligible study subjects. Study subjects will be prospective consented and enrolled and will have baseline "out of clinic" assessment with the Vibrent smartphone application (research procedure).

Do I qualify?Apply below to find out